Expert Outlook: Alphatec Holdings Through The Eyes Of 7 Analysts
Alphatec Holdings (NASDAQ:ATEC) underwent analysis by 7 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 7 | 0 | 0 | 0 | 0 |
| Last 30D | 1 | 0 | 0 | 0 | 0 |
| 1M Ago | 0 | 0 | 0 | 0 | 0 |
| 2M Ago | 4 | 0 | 0 | 0 | 0 |
| 3M Ago | 2 | 0 | 0 | 0 | 0 |
In the assessment of 12-month price targets, analysts unveil insights for Alphatec Holdings, presenting an average target of $21.57, a high estimate of $25.00, and a low estimate of $19.00. Witnessing a positive shift, the current average has risen by 5.22% from the previous average price target of $20.50.
Exploring Analyst Ratings: An In-Depth Overview
An in-depth analysis of recent analyst actions unveils how financial experts perceive Alphatec Holdings. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| David Saxon | Needham | Maintains | Buy | $23.00 | - |
| David Saxon | Needham | Raises | Buy | $23.00 | $22.00 |
| Caitlin Cronin | Canaccord Genuity | Maintains | Buy | $25.00 | - |
| David Saxon | Needham | Raises | Buy | $22.00 | $19.00 |
| David Saxon | Needham | Maintains | Buy | $19.00 | - |
| Sean Lee | HC Wainwright & Co. | Maintains | Buy | $20.00 | - |
| David Saxon | Needham | Maintains | Buy | $19.00 | - |
Key Insights:
- Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Alphatec Holdings. This information provides a snapshot of how analysts perceive the current state of the company.
- Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Alphatec Holdings compared to the broader market.
- Price Targets: Analysts navigate through adjustments in price targets, providing estimates for Alphatec Holdings's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.
For valuable insights into Alphatec Holdings's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
Stay up to date on Alphatec Holdings analyst ratings.
If you are interested in following small-cap stock news and performance you can start by tracking it here.
About Alphatec Holdings
Alphatec Holdings Inc is a medical technology company focused on the designing, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others.
Financial Insights: Alphatec Holdings
Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.
Positive Revenue Trend: Examining Alphatec Holdings's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 30.23% as of 31 December, 2023, showcasing a substantial increase in top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Health Care sector.
Net Margin: Alphatec Holdings's net margin falls below industry averages, indicating challenges in achieving strong profitability. With a net margin of -35.57%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Alphatec Holdings's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of -289.08%, the company may face hurdles in achieving optimal financial performance.
Return on Assets (ROA): Alphatec Holdings's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of -6.65%, the company may face hurdles in achieving optimal financial returns.
Debt Management: Alphatec Holdings's debt-to-equity ratio is notably higher than the industry average. With a ratio of 6.93, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.
Analyst Ratings: Simplified
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
This article was generated by Benzinga's automated content engine and reviewed by an editor.